PFE
Pfizer Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Pfizer Inc. is a leading global pharmaceutical and biotechnology company headquartered in New York City, boasting a distinguished history of innovation since 1849. With a comprehensive therapeutic portfolio that includes key areas such as immunology, oncology, and cardiology, Pfizer is committed to ...
$25.79
+0.49% (+$0.13)
Volume
35.51M
52W High
$28.75
52W Low
$22.81
Market Cap
$149.80B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.68
Whisper EPS
$0.76
11.3% above consensus
Last Quarter
$0.75
Current Streak
7 Beats
Avg Surprise (4Q)
+23.72%
Next Earnings Report
Reports in 68 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 5, 2026
1-Day:
+0.30%
Q1 2026
Apr 28, 2026
1-Day:
-0.83%
Q4 2025
Feb 3, 2026
1-Day:
+3.92%
Q3 2025
Nov 4, 2025
1-Day:
+1.28%
Revenue & Financial Performance
Revenue Whisper
$14.16B
TWN Proprietary Estimate
Last Quarter Revenue
$14.45B
+5.4% YoY
Gross Margin
67.3%
Net Margin: 18.6%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $14.45B | +5.4% | 67.3% | 27.9% | $2.69B |
| Q4'25 | $17.56B | -1.2% | 70.0% | 21.0% | -$1.65B |
| Q3'25 | $16.65B | -5.9% | 75.0% | 21.3% | $3.54B |
| Q2'25 | $14.65B | +10.3% | 64.3% | 24.4% | $2.91B |
| Q1'25 | $13.72B | -7.8% | 71.7% | 33.7% | $2.97B |
| Q4'24 | $17.76B | +21.9% | 73.0% | 32.2% | $403.0M |
| Q3'24 | $17.70B | +31.2% | 60.9% | 28.1% | $4.47B |
| Q2'24 | $13.28B | +4.3% | 62.1% | 14.2% | $24.0M |
Company Information
Symbol
PFE
Company
Pfizer Inc
Market Cap
$149.80B
Sector
HEALTHCARE
Next Earnings
Jul 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as PFE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare PFE with competitors
Side-by-side earnings comparison